Clinical Trials Browser

Phase 2 × Disease × Melphalan × Clear all

NCT01190787 2024-01-23

Subcutaneous Velcade Plus Oral Melphalan and Prednisone or Plus Cycloposphamide and Prednisone or Plus Prednisone

Phase 2 Completed

Disease, Multiple Myeloma

NCT01160107 2023-06-29

RP_MPR

Phase 2 Completed

Disease, Multiple Myeloma